Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes and Healthy Control”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT01881919
What this trial is testing

Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial

Who this might be right for
HyperuricemiaGoutKidney Calculi+2 more
University of Leeds 22
Early research (Phase 1)Study completedNCT00537719
What this trial is testing

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT01031108
What this trial is testing

A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Sirtris, a GSK Company 38
Very early researchTemporarily pausedNCT06845943
What this trial is testing

A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes

Who this might be right for
Obesity and Overweight
Helicore Biopharma, Inc. 48
Early research (Phase 1)Active Not RecruitingNCT07736391
What this trial is testing

SYH2069 Injection in Healthy Participants

Who this might be right for
Overweight or ObesityDiabetes
CSPC Ouyi Pharmaceutical Co., Ltd. 104
Post-approval studies (Phase 4)Study completedNCT04027530
What this trial is testing

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseDiabetic Nephropathy+4 more
Amsterdam UMC, location VUmc 40
Early research (Phase 1)Ended earlyNCT00887445
What this trial is testing

First in Man Study With SLV341

Who this might be right for
Diabetes
Solvay Pharmaceuticals 87
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Early research (Phase 1)Study completedNCT00673621
What this trial is testing

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

Who this might be right for
AsthmaDiabetes Mellitus
Mannkind Corporation 30
Early research (Phase 1)Study completedNCT01776528
What this trial is testing

Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants

Who this might be right for
Diabetes Mellitus
NGM Biopharmaceuticals, Inc 119
Testing effectiveness (Phase 2)Ended earlyNCT01551381
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects

Who this might be right for
Type 2 Diabetes
Evolva SA 33
Not applicableLooking for participantsNCT06064669
What this trial is testing

Effect of Metformin on Healthy Live Birth in Women With Prediabetes

Who this might be right for
MetforminPrediabetesIn-Vitro Fertilization
Shandong University 988
Large-scale testing (Phase 3)Study completedNCT00651105
What this trial is testing

Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Who this might be right for
Type-2 DiabetesHealthy
Novartis 63
Early research (Phase 1)Study completedNCT01571661
What this trial is testing

A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT06703658
What this trial is testing

Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus

Who this might be right for
Healthy ParticipantsType 2 Diabetes
AstraZeneca 35
Early research (Phase 1)UnknownNCT00961025
What this trial is testing

Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects

Who this might be right for
Diabetes Mellitis Type 2
Dong-A Pharmaceutical Co., Ltd. 110
Early research (Phase 1)Not Yet RecruitingNCT07518121
What this trial is testing

A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil

Who this might be right for
Diabete Type 2
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 48
Early research (Phase 1)Study completedNCT00501930
What this trial is testing

Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
GlaxoSmithKline 12
Not applicableStudy completedNCT00364767
What this trial is testing

Moderate Alcohol Consumption, Fat and Carbohydrate Metabolism and Insulin Sensitivity

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular Disease
TNO 19
Early research (Phase 1)Study completedNCT01217905
What this trial is testing

Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687

Who this might be right for
Type 2 DiabetesObesity
AstraZeneca 36
Next Page